IRS Releases Tax Guidance for Cannabis Industry
The Internal Revenue Service (“IRS”) last Thursday released updated guidance on a stand-alone web page for the state-legal marijuana industry. The new guidance covers the rules for IRC Section 280E, income reporting, reporting case transactions over $10,000, cash payment options, estimating tax payments, and keeping financial records.
“A key component in promoting the highest degree of voluntary compliance on the part of taxpayers is helping them understand and meet their tax responsibilities while also enforcing the law with integrity and fairness to all,” the web page states.
This update appears to be responsive to a Treasury Department internal watchdog report that was released in April. The department’s inspector general for tax administration had criticized IRS for failing to adequately advise taxpayers in the marijuana industry about compliance with federal tax laws.
In a related FAQ, the IRS goes into further detail about specific issues that are particularly problematic for the marijuana industry, including general tax obligations, payment plans, penalties that can be incurred in an audit, deductions that businesses can and cannot make under IRC Sections 280E and 471 concerning calculation of costs of goods sold, and more detailed obligations concerning cash payments over $10,000.
While the new guidance will presumably provide some consistency to the IRS’s treatment of the industry, we strongly recommend that businesses engage competent and experienced tax advisors and counsel to lower tax risk associated with operating a cannabis business.
Contact Dan Garfield, dgarfield@mcallistergarfield.com, 720-722-0048, if you have questions about this IRS guidance or need assistance with entity structuring entity to help minimize the tax burden the cannabis industry faces.
Related Article
Psychedelic Therapy & Law Update – April 2026
President Trump to Issue Executive Order on Ibogaine President Trump will sign an executive order opening doors for more federal reserach on ibogaine, the naturally occuring psychedelic substance with indigenous roots in Africa. For more information, see this article by clicking here. Ibogaine has shown significant benefits for veterans suffering from war trauma, those suffering from […]
Psychedelic Therapy & Law Update – March 2026
Colorado starts the rulemaking process again for NMHA program changes DOR Natural Medicine Division is proposing several rules changes to the NMHA rules. These proposed changes include a significant increase in the cost of standard healing center licenses (from $6k to over $10k). Other proposed changes include adding an owner entity fee, prohibiting cultivator sampling […]
Psychedelic Therapy & Law Update – February 2026
Maryland and New Jersey moving toward creation of psilocybin programs The Maryland Task Force on Responsible Use of Natural Psychedelic Substances, in a report near the end of 2025 endorsed the creation of a regulated psilocybin program in the state. The recommendation still needs to be adopted by the Maryland legislature, but this is an […]